Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Clinical malnutrition is a disease condition that can be treated only with clinical intervention, through the use of specialized nutrients that are considered as proper medications, rather than as supplements. Clinical nutrition products help to keep the patient healthy and aid to improve the metabolic system of the body by providing adequate supplements, such as minerals, vitamins, and other supplements. Additionally, the high birth rate and a higher number of premature births also demand the advanced clinical nutrition. Clinical nutrition products help to improve digestion, metabolisms, absorption, transportation, storage and discharge from the human body.
The clinical nutrition market growth is propelled by factors including the increasing prevalence of metabolic disorders, high spending on healthcare, and rise of middle class in the emerging economies. It has also been observed that healthcare expenditure continues to grow faster than economic growth in most of the countries, maintaining a trend observed over decades. Therefore, as the healthcare spending increases among major countries of the world, because of its wide applicability, the market is expected to witness a high growth.
Over the years, the prevalence of metabolic disorders has increased, in terms of raw data. The actual number of patients opting for the diagnosis of metabolic disorders has increased over the last decade, thereby resulting in the increase in the number of patients diagnosed. Thus, with the rising prevalence of the metabolic diseases, there is a great opportunity for the market players to tap the emerging markets and establish their presence.
Geographically, the market is segmented into Asia-Pacific, North America, Europe and RoW. The Asia Pacific clinical nutrition market is projected to grow at the highest CAGR during the forecast period 2020 to 2026. Asia-Pacific has the highest growth, in comparison to the other regions, in the forecast period, mainly due to high levels of malnutrition and the presence of severe chronic diseases in the region. Thus, due to the increased metabolic disorders and rising income inequality in various countries, the region is also expected to witness robust growth over the forecast period.
The oral & enteral and parenteral nutrition are the major segments of clinical nutrition products. Enteral nutrition consumed orally such as nutritional drinks and provide nutrients to the patients who cannot ingest. Parenteral nutrients provided to patients through feeding tube. The oral and enteral segment accounted for the largest share in 2019, as they are used the most, followed by parenteral route. This is mainly because of the additional cost of processing the product/nutrient involved in enteral/parenteral routes.
Various applications of the clinical nutrition are malnutrition, metabolic disorders, gastrointestinal diseases, neurological diseases, cancer and other diseases. Moreover, paediatric and adult are the end users of these products.
The key companies in the clinical nutrition market are Abbott Nutrition, B. Braun Melsungen, Baxter International, Claris Lifesciences, Claris Otsuka Private, Fresenius Kabi, Groupe Danone, Huarui Pharmaceutical, ICU Medical, Mead Johnson Nutrition, Meiji, Nestlé Health Science, Nutricia North America and Otsuka Pharmaceutical Factory. The industry players are found focusing on expansion through various inorganic strategies, such as acquisition, merger, strategic collaboration, and others, to gain significant market share and strengthen their product portfolios. Thus, the growing awareness about clinical nutrition has boosted the demand for pediatric, as well as adult nutrition formulae.
The report analyses the global clinical nutrition market based on route of administration, end user, application and geography. The oral & enteral and parenteral nutrition are the major segments of clinical nutrition products. Enteral nutrition consumed orally such as nutritional drinks and provide nutrients to the patients who cannot ingest. Parenteral nutrients provided to patients through feeding tube. Infant nutrients can be milk-based or soy-based and helps in stages of development of infants. Infant nutrition is the fastest growing segment in the clinical nutrition products market.
Various applications of the clinical nutrition are malnutrition, metabolic disorders, gastrointestinal diseases, neurological diseases, cancer and other diseases. Moreover, paediatric and adult are the end users of these products.
Why to buy this report:
